News & Views

"My policy as a doctor was always to be very open and transparent – whether that was about morbidity or mortality I was very open."...
The choices in the drug development model to navigate clinical pathways, and the relationship between drug developers and CROs/ CDMOs can be incredibly complex...
Louis Garguilo, Chief Editor, Outsourced Pharma, has published the latest part of his interview with Ali Pashazadeh, CEO, Treehill where Ali details why we think biopharmas and outsourced providers need strategic help to focus more on profitability...